PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

Pulmonary Hypertension

Interventions

DRUG

PET/MR with 18F-FDG

(18F) Fluorodeoxyglucose (FDG) will be administered by intravenous injection at a dose of 4-5 MBq/kg.

Trial Locations (1)

RECRUITING

University Health Network, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER